Sigma Capital

19-06-2025

Cash Capital Increase (Due To Merger) for FERCHEM MISR CO . FOR FERTILLIZERS& CHEMICALS (SMEs Market)

Source: EGX

The listing committee held on 18/06/2025 has approved the following:-
First: List the authorized capital amendment of FERCHEM MISR CO . FOR FERTILLIZERS& CHEMICALS, from EGP 100 Million to EGP 2 Billion.
Second: List the issued capital increase from EGP 35,100,000 to EGP 800 Million with an increase of EGP 764,900,000 distributed over 382,450,000 shares. Such increase is due to the merger of Abou Zaabal for Fertilizers and Chemical Materials (the merged company - not listed in the EGX list) & Aswan for Fertilizers and Chemical Industries (the merged company - not listed in the EGX list) into FERCHEM MISR CO . FOR FERTILLIZERS& CHEMICALS (the merging company - listed in the EGX list).
As a result of the merger, the issued capital of the merging company will be EGP 800 Million after the amendment, distributed over 400 Million shares with a Par value of EGP 2.00 per share representing the 4th issuance, to be listed in the Egyptian Securities Listing schedule "Shares", where the new shares of such increase shall be added to EGX database, as of the beginning of the trading session on Sunday 22 June, 2025.
Third: Amend the listing of the companys shares from the SME market — In accordance with the provisions of Article (9) of the listing and delisting rules — to be listed on the Main market In accordance with the provisions of Article (7) of the listing and delisting rules. In light of the provisions of Clause (1) of Article 23 bis of the listing and delisting rules, This amendment will be effective from the beginning of the trading session on Sunday 22 June, 2025.

Continuing to suspend trading in the company’s shares until the company complies with the requirements of FRA contained in its approval issued on 09/24/2024 to publish the disclosure report in accordance with Article (48) of the Listing rules, then the company’s Case to be presented to the Operations Committee of EGX to determine the market in which the company’s shares will be traded, the opening price, and the date of the start of trading in the company’s shares, after publishing the disclosure report approved by FRA.